Hidekazu Maruyama

502 total citations
35 papers, 394 citations indexed

About

Hidekazu Maruyama is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Hidekazu Maruyama has authored 35 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 8 papers in Cardiology and Cardiovascular Medicine and 7 papers in Molecular Biology. Recurrent topics in Hidekazu Maruyama's work include Pulmonary Hypertension Research and Treatments (14 papers), Cardiovascular Function and Risk Factors (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Hidekazu Maruyama is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), Cardiovascular Function and Risk Factors (5 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). Hidekazu Maruyama collaborates with scholars based in Japan, Belgium and United States. Hidekazu Maruyama's co-authors include Masafumi Onodera, Satoshi Sakai, Naoki Oka, Akio Soeda, Hideki Mori, Takahiro Kunisada, Akira Hara, Toru Iwama, Akihito Inagaki and Céline Dewachter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Hidekazu Maruyama

33 papers receiving 388 citations

Peers

Countries citing papers authored by Hidekazu Maruyama

Since Specialization

Citations

This map shows the geographic impact of Hidekazu Maruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidekazu Maruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidekazu Maruyama more than expected).

Fields of papers citing papers by Hidekazu Maruyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidekazu Maruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidekazu Maruyama. The network helps show where Hidekazu Maruyama may publish in the future.

Co-authorship network of co-authors of Hidekazu Maruyama

This figure shows the co-authorship network connecting the top 25 collaborators of Hidekazu Maruyama. A scholar is included among the top collaborators of Hidekazu Maruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidekazu Maruyama. Hidekazu Maruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Prostacyclin receptor agonists induce DUSP1 to inhibit pulmonary artery smooth muscle cell proliferation 2023 ·Life Sciences ·Hidekazu Maruyama, Satoshi Sakai, Laurence Dewachter, Céline Dewachter, Benoı̂t Rondelet, Robert Naeije, Masaki Ieda	6
2	Acute venodilation properties of low-dose intravenous nitroglycerine in pulmonary veno-occlusive disease: a case report 2023 ·European Heart Journal - Case Reports ·Hidekazu Maruyama, Satoshi Sakai, Shoji Suzuki	1
3	Administration of β-lactam antibiotics and delivery method correlate with intestinal abundances of Bifidobacteria and Bacteroides in early infancy, in Japan 2021 ·Scientific Reports ·(unknown), (unknown), (unknown), Hiroto Morita, (unknown), Hidekazu Maruyama, Shuko Nojiri, Naoyuki Hashiguchi, Shin Watanabe	18
4	The Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Improves Hypoxia-Induced Pulmonary Hypertension in Mice Partly via Normalization of Reduced ETB Receptor Expression 2018 ·Physiological Research ·(unknown), Takeshi Kimura, Satoshi Sakai, Hidekazu Maruyama, Kazuko Tajiri, Nobuyuki Murakoshi, (unknown), T. Miyauchi, Kazutaka Aonuma	16
5	Maternal antimicrobial use at delivery has a stronger impact than mode of delivery on bifidobacterial colonization in infants: a pilot study 2018 ·Journal of Perinatology ·(unknown), Hiroto Morita, (unknown), Hidekazu Maruyama, Shin Watanabe, Naoyuki Hashiguchi	24
6	Antagonists to endothelin receptor type B promote apoptosis in human pulmonary arterial smooth muscle cells 2016 ·Life Sciences ·Satoshi Sakai, Hidekazu Maruyama, Taizo Kimura, Kazuko Tajiri, (unknown), (unknown), Kazutaka Aonuma, Takashi Miyauchi	7
7	Bosentan reverses the hypoxia-induced downregulation of the bone morphogenetic protein signaling in pulmonary artery smooth muscle cells 2016 ·Life Sciences ·Hidekazu Maruyama, Céline Dewachter, Satoshi Sakai, Asmae Belhaj, Benoı̂t Rondelet, Myriam Remmelink, Jean‐Luc Vachiéry, Robert Naeije, Laurence Dewachter	9
8	Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension 2014 ·The Journal of Heart and Lung Transplantation ·Hidekazu Maruyama, Céline Dewachter, Asmae Belhaj, Benoı̂t Rondelet, Satoshi Sakai, Myriam Remmelink, Jean‐Luc Vachiéry, Robert Naeije, Laurence Dewachter	26
9	Involvement of peptidyl-prolyl isomerase Pin1 in the inhibitory effect of fluvastatin on endothelin-1-induced cardiomyocyte hypertrophy 2014 ·Life Sciences ·Satoshi Sakai, Nobutake Shimojo, Taizo Kimura, Kazuko Tajiri, Hidekazu Maruyama, (unknown), Keisuke Kuga, (unknown), Kazutaka Aonuma, Takashi Miyauchi	14
10	Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats 2014 ·Life Sciences ·(unknown), Subrina Jesmin, Satoshi Sakai, (unknown), Nobutake Shimojo, (unknown), (unknown), Sohel Zaedi, Seiji Maeda, Hidekazu Maruyama, Taro Mizutani, (unknown), Kazutaka Aonuma, Takashi Miyauchi	10
11	Elevation of plasma basic fibroblast growth factor after nocturnal hypoxic events in patients with obstructive sleep apnea syndrome 2013 ·SpringerPlus ·(unknown), (unknown), Hidekazu Maruyama, Kazutaka Aonuma, Makoto Satoh	3
12	The case of pulmonary veno-occlusive disease succeeded in administration of sildenafil by dose adjustment 2013 ·Life Sciences ·Akinori Sugano, Satoshi Sakai, Hidekazu Maruyama, Taizo Kimura, Tomoko Ishizu, Yoshihiro Seo, (unknown), Takashi Miyauchi, Kazutaka Aonuma	0
13	The hypoxia-mimetic agent cobalt chloride induces the expression of intrinsic BMP antagonist noggin independent /INS;of the /INS;endothelin pathway 2013 ·Life Sciences ·Hidekazu Maruyama, Céline Dewachter, Satoshi Sakai, Asmae Belhaj, Benoı̂t Rondelet, Myriam Remmelink, Jean‐Luc Vachiéry, Robert Naeije, Laurence Dewachter	1
14	Endothelin-1induced cardiomyocyte hypertrophy is partly regulated by transcription factor II-F interacting C-terminal domain phosphatase of RNA polymerase II 2012 ·Life Sciences ·Satoshi Sakai, Taizo Kimura, Zheng Wang, Nobutake Shimojo, Hidekazu Maruyama, (unknown), Keisuke Kuga, Iwao Yamaguchi, Kazutaka Aonuma, Takashi Miyauchi	6
15	VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells 2007 ·Biochemical and Biophysical Research Communications ·Naoki Oka, Akio Soeda, Akihito Inagaki, Masafumi Onodera, Hidekazu Maruyama, Akira Hara, Takahiro Kunisada, Hideki Mori, Toru Iwama	119
16	Continuous Intravenous Administration of a Low Dose of Epoprostenol Greatly Decreased Serum Concentrations of Endothelin-1 in Primary Pulmonary Hypertension 2005 ·Angiology ·Yoshihiko Kakinuma, (unknown), Takashi Morimoto, Hidekazu Maruyama, Akira Yamazaki, Toshiyuki Ishimitsu, Iwao Yamaguchi	1
17	A case of adenocarcinoma of the endometrial type mixed with a clear cell component that metastasized to the vagina. 2003 ·PubMed ·Yoshihito Yokoyama, Akiko Sakamoto, M Umemoto, Masayuki Futagami, Toshihiko Sakamoto, Hidekazu Maruyama, (unknown), Hiroshi Mizunuma	1
18	Primary non-Hodgkin's lymphoma of the uterine cervix 2001 ·Archives of Gynecology and Obstetrics ·Yoshihito Yokoyama, Shigemi Sato, (unknown), Kohei Tanaka, Hidekazu Maruyama, Yoshiharu Saito	7
19	Low serum lipids suggest severe bone marrow failure in children with aplastic anemia 2000 ·Pediatrics International ·Masaru Yokoyama, (unknown), Hideko Sato, Koji Arai, Shinobu Waga, Junichi Kitazawa, Hidekazu Maruyama, Etsuro Ito	15
20	INHIBITORY EFFECT OF MILRINONE ON CYTOKINE PRODUCTION AFTER CARDIOPULMONARY BYPASS 1999 ·ASAIO Journal ·Nobuhiko Hayashida, Hiroshi Tomoeda, Teiji Oda, Eiki Tayama, (unknown), Hidekazu Maruyama, Takemi Kawara, S Aoyagi	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact